László Petri

556 total citations
25 papers, 408 citations indexed

About

László Petri is a scholar working on Organic Chemistry, Molecular Biology and Oncology. According to data from OpenAlex, László Petri has authored 25 papers receiving a total of 408 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Organic Chemistry, 18 papers in Molecular Biology and 11 papers in Oncology. Recurrent topics in László Petri's work include Click Chemistry and Applications (13 papers), Chemical Synthesis and Analysis (12 papers) and Peptidase Inhibition and Analysis (8 papers). László Petri is often cited by papers focused on Click Chemistry and Applications (13 papers), Chemical Synthesis and Analysis (12 papers) and Peptidase Inhibition and Analysis (8 papers). László Petri collaborates with scholars based in Hungary, Slovenia and United Kingdom. László Petri's co-authors include György M. Keserű, Péter Ábrányi‐Balogh, Tı́mea Imre, Aaron Keeley, Stanislav Gobec, György G. Ferenczy, Martina Hrast, Andrea Scarpino, Péter A. Szijj and Janez Ilaš and has published in prestigious journals such as Angewandte Chemie International Edition, SHILAP Revista de lepidopterología and Journal of Medicinal Chemistry.

In The Last Decade

László Petri

25 papers receiving 404 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
László Petri Hungary 11 286 231 104 76 33 25 408
John Strelow United States 7 247 0.9× 129 0.6× 84 0.8× 65 0.9× 32 1.0× 9 365
Fandi Sutanto Netherlands 6 204 0.7× 163 0.7× 69 0.7× 53 0.7× 23 0.7× 9 343
Savithri Ramurthy United States 12 284 1.0× 194 0.8× 93 0.9× 85 1.1× 19 0.6× 17 405
Christoph Arkona Germany 12 363 1.3× 162 0.7× 38 0.4× 60 0.8× 28 0.8× 24 487
Xiaobo Wan China 7 380 1.3× 323 1.4× 49 0.5× 81 1.1× 63 1.9× 11 545
Mihiret T. Sisay Germany 9 214 0.7× 83 0.4× 118 1.1× 53 0.7× 19 0.6× 12 365
Kareem Khoury United States 16 361 1.3× 409 1.8× 80 0.8× 123 1.6× 14 0.4× 22 644
Jonathan M. Large United Kingdom 17 224 0.8× 308 1.3× 90 0.9× 46 0.6× 16 0.5× 35 594
Maxim Frizler Germany 11 278 1.0× 155 0.7× 36 0.3× 128 1.7× 14 0.4× 18 466
Cynthia Hess Kenny United States 10 270 0.9× 107 0.5× 55 0.5× 41 0.5× 51 1.5× 17 420

Countries citing papers authored by László Petri

Since Specialization
Citations

This map shows the geographic impact of László Petri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by László Petri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites László Petri more than expected).

Fields of papers citing papers by László Petri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by László Petri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by László Petri. The network helps show where László Petri may publish in the future.

Co-authorship network of co-authors of László Petri

This figure shows the co-authorship network connecting the top 25 collaborators of László Petri. A scholar is included among the top collaborators of László Petri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with László Petri. László Petri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Petri, László, et al.. (2025). Target Agnostic Photoaffinity Labelling by Sulfonylhydrazones. Angewandte Chemie International Edition. 64(17). e202408701–e202408701. 1 indexed citations
2.
Petri, László, Ronen Gabizon, György G. Ferenczy, et al.. (2025). Size-Dependent Target Engagement of Covalent Probes. Journal of Medicinal Chemistry. 68(6). 6616–6632. 4 indexed citations
3.
Lorenzo, V. di, László Petri, Elvin D. de Araujo, et al.. (2025). Allosteric Covalent Inhibitors of the STAT3 Transcription Factor from Virtual Screening. ACS Medicinal Chemistry Letters. 16(6). 991–997. 1 indexed citations
4.
Ábrányi‐Balogh, Péter, László Petri, Tı́mea Imre, et al.. (2024). Site-Selective Antibody Conjugation with Dibromopyrazines. Bioconjugate Chemistry. 35(9). 1373–1379. 4 indexed citations
5.
Ranđelović, Ivan, Attila Egyed, László Petri, et al.. (2024). Contribution of Noncovalent Recognition and Reactivity to the Optimization of Covalent Inhibitors: A Case Study on KRasG12C. ACS Chemical Biology. 19(8). 1743–1756. 2 indexed citations
6.
Petri, László, Péter Ábrányi‐Balogh, Aaron Keeley, et al.. (2023). Activation-Free Sulfonyl Fluoride Probes for Fragment Screening. Molecules. 28(7). 3042–3042. 5 indexed citations
7.
Petri, László, Péter Ábrányi‐Balogh, Szilárd Tóth, et al.. (2023). Covalent fragment mapping of KRasG12C revealed novel chemotypes with in vivo potency. European Journal of Medicinal Chemistry. 250. 115212–115212. 3 indexed citations
8.
Keeley, Aaron, V. di Lorenzo, Péter Ábrányi‐Balogh, et al.. (2023). Electrophilic MiniFrags Revealed Unprecedented Binding Sites for Covalent HDAC8 Inhibitors. Journal of Medicinal Chemistry. 67(1). 572–585. 8 indexed citations
9.
Petri, László, Péter Ábrányi‐Balogh, Tı́mea Imre, et al.. (2022). A covalent strategy to target intrinsically disordered proteins: Discovery of novel tau aggregation inhibitors. European Journal of Medicinal Chemistry. 231. 114163–114163. 13 indexed citations
10.
Hrast, Martina, Irena Zdovc, Tı́mea Imre, et al.. (2022). Covalent inhibitors of bacterial peptidoglycan biosynthesis enzyme MurA with chloroacetamide warhead. European Journal of Medicinal Chemistry. 243. 114752–114752. 13 indexed citations
11.
Ábrányi‐Balogh, Péter, Aaron Keeley, György G. Ferenczy, et al.. (2022). Next-Generation Heterocyclic Electrophiles as Small-Molecule Covalent MurA Inhibitors. Pharmaceuticals. 15(12). 1484–1484. 7 indexed citations
12.
Gobec, Martina, Damijan Knez, Péter Ábrányi‐Balogh, et al.. (2021). Discovery of selective fragment-sized immunoproteasome inhibitors. European Journal of Medicinal Chemistry. 219. 113455–113455. 14 indexed citations
13.
Petri, László, Attila Egyed, Dávid Bajusz, et al.. (2020). An electrophilic warhead library for mapping the reactivity and accessibility of tractable cysteines in protein kinases. European Journal of Medicinal Chemistry. 207. 112836–112836. 35 indexed citations
14.
Ábrányi‐Balogh, Péter, László Petri, Attila Mészáros, et al.. (2020). Targeting an Intrinsically Disordered Protein by Covalent Modification. Methods in molecular biology. 2141. 835–854. 2 indexed citations
15.
Petri, László, et al.. (2020). Comparative reactivity analysis of small-molecule thiol surrogates. Bioorganic & Medicinal Chemistry. 28(7). 115357–115357. 29 indexed citations
16.
Keeley, Aaron, László Petri, Péter Ábrányi‐Balogh, & György M. Keserű. (2020). Covalent fragment libraries in drug discovery. Drug Discovery Today. 25(6). 983–996. 71 indexed citations
17.
Hamilton, David J., Péter Ábrányi‐Balogh, Aaron Keeley, et al.. (2020). Bromo-Cyclobutenaminones as New Covalent UDP-N-Acetylglucosamine Enolpyruvyl Transferase (MurA) Inhibitors. Pharmaceuticals. 13(11). 362–362. 24 indexed citations
18.
Petri, László, Péter Ábrányi‐Balogh, Tı́mea Imre, et al.. (2020). Assessment of Tractable Cysteines for Covalent Targeting by Screening Covalent Fragments. ChemBioChem. 22(4). 743–753. 19 indexed citations
19.
Petri, László, et al.. (2020). Prospective Evaluation of Spent Sulfuric Acid Recovery by Process Simulation. Periodica Polytechnica Chemical Engineering. 65(2). 243–250. 3 indexed citations
20.
Ábrányi‐Balogh, Péter, László Petri, Tı́mea Imre, et al.. (2018). A road map for prioritizing warheads for cysteine targeting covalent inhibitors. European Journal of Medicinal Chemistry. 160. 94–107. 90 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by John Strelow Breakdown of academic impact, for papers by Fandi Sutanto Breakdown of academic impact, for papers by Savithri Ramurthy Breakdown of academic impact, for papers by Christoph Arkona Breakdown of academic impact, for papers by Xiaobo Wan Breakdown of academic impact, for papers by Mihiret T. Sisay Breakdown of academic impact, for papers by Kareem Khoury Breakdown of academic impact, for papers by Jonathan M. Large Breakdown of academic impact, for papers by Maxim Frizler Breakdown of academic impact, for papers by Cynthia Hess Kenny
Rankless by CCL
2026